Myeloid Suppressor Cells, Methods For Preparing Them, and Methods For Using Them For Treating Autoimmunity
AssigneeMount Sinai School of Medicine of New York University
InventorShu-Hsia Chen
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel myeloid suppressor cells (MSCs) and to methods of isolating these MSCs are also included. The MSCs of the present invention can be used to treat or prevent autoimmune diseases or alloimmune responses. The MSCs of the present invention may also be used to reduce a T cell response, induce T regulatory cells, and produce T cell tolerance.
Claims49
A method of treating an autoimmune disease in an individual, which method comprises administering a therapeutically effective amount of myeloid suppressor cells (MSCs) to the individual, wherein the MSCs have a Gr-1+/CD11b+ phenotype.
A method of treating an alloimmune response in an individual, which method comprises administering a therapeutically effective amount of myeloid suppressor cells (MSCs) to the individual, wherein the MSCs have a Gr-1+/CD11b+ phenotype.
A method of producing myeloid suppressor cells (MSCs), which method comprises culturing primary hematopoietic stem cells (HSCs) in the presence of stem-cell factor (SCF) in an amount and for a time sufficient to allow HSCs to differentiate into MSCs, wherein the MSCs have a Gr-1+/CD11b+ phenotype.
Dependencies are inferred from the claim text.